Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma

Figure 5 Analysis of LAPTM4B-35 via TMA. A: Scores assigned to each tissue spot according to three different staining coverages. Negative represents the complete negative staining. Weak represents scores assigned to tissue disks with borderline and partial positive staining. The complete positive staining was designated as strong; B: Representative elements of a TMA stained with LAPTM4B-N_1-99-pAb. Magnification ×200. Normal tissue stained with LAPTM4B-N_1-99-pAb (A1: esophageal mucous; B1: mammary gland tissue; C1: normal lung tissue; D1: gastric mucous; E1: colonic mucous; F1: rectal mucous). Tumor tissue stained with LAPTM4B- N_1-99-pAb (A2: esophageal carcinoma; B2: breast cancer; C2: pulmonary carcinoma; D2: gastric carcinoma; E2: colon carcinoma; F2: rectal carcinoma.); C: Histogram of LAPTM4B expression assessed using 6 TMAs.